Ridley Quoted in Bloomberg Law About How COVID-19 Pandemic Creates More Opportunities for Infringers
24 April 2020
Partner Eileen Ridley was quoted in the Bloomberg Law article, “Virus Leaves Brands to Protect Themselves as Opportunists Pounce,” about how the coronavirus pandemic is creating more opportunities for companies producing knock-offs.
Stay-at-home orders have pushed a higher share of shopping online amid shortages of health and safety products, making the virtual world an obvious focus for infringers. Potential victims aren’t merely more numerous, but in some cases more vulnerable, Ridley said. “With such proliferation of online shopping, you have a bunch of inexperienced people using mechanisms they’re not adept at using.”
Knock-offs of ventilators, test kits, masks, hand sanitizers, and other supplies to help treat and guard against the virus that are selling for “extraordinary prices” are “definitely widespread,” Ridley said.
Stay-at-home orders have pushed a higher share of shopping online amid shortages of health and safety products, making the virtual world an obvious focus for infringers. Potential victims aren’t merely more numerous, but in some cases more vulnerable, Ridley said. “With such proliferation of online shopping, you have a bunch of inexperienced people using mechanisms they’re not adept at using.”
Knock-offs of ventilators, test kits, masks, hand sanitizers, and other supplies to help treat and guard against the virus that are selling for “extraordinary prices” are “definitely widespread,” Ridley said.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”